Magnetic resonance spectroscopy in patients with MELAS

被引:52
作者
Möller, HE
Kurlemann, G
Pützler, M
Wiedermann, D
Hilbich, T
Fiedler, B
机构
[1] Max Planck Inst Human Cognit & Brain Sci, D-04103 Leipzig, Germany
[2] Univ Klinikum Munster, Klin & Poliklin Kinderheilkunde Neuropadiatrie, D-48129 Munster, Germany
[3] Raphaelsklin Munster, D-48143 Munster, Germany
[4] Max Planck Inst Neurol Res, D-50866 Cologne, Germany
[5] Univ Munster, Inst Phys Chem, D-48149 Munster, Germany
关键词
creatine kinase; energy metabolism; gray matter; magnetic resonance spectroscopy; MELAS; skeletal muscle;
D O I
10.1016/j.jns.2004.11.014
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Localized magnetic resonance spectroscopy (MRS) yields sensitive metabolic markers to provide insight into the pathophysiology of mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) in vivo. Findings in full MELAS syndrome at H-1 MRS of the brain typically include severely elevated lactate and reduced N-acetylaspartate, glutamate, myo-inositol, and total creatine concentrations in stroke-like lesions. Similar but less extreme alterations are also common in gray matter (GM) regions that appear normal at magnetic resonance imaging. Phosphorus spectroscopy of peripheral muscle permits investigation of the bioenergetic status. A decline of the phosphorylation potential indicates a low energy reserve at rest. Phosphocreatine resynthesis during post-exercise recovery is delayed pointing to reduced mitochondrial capacity. As MRS is inherently non-invasive, follow-up studies can be performed to assess treatment response quantitatively. (c) 004 Elsevier B.V. All rights reserved.
引用
收藏
页码:131 / 139
页数:9
相关论文
共 48 条
[1]   BIOENERGETIC HETEROGENEITY OF HUMAN MITOCHONDRIAL MYOPATHIES - PHOSPHORUS MAGNETIC-RESONANCE SPECTROSCOPY STUDY [J].
ARGOV, Z ;
BANK, WJ ;
MARIS, J ;
PETERSON, P ;
CHANCE, B .
NEUROLOGY, 1987, 37 (02) :257-262
[2]   INVESTIGATION OF HUMAN MITOCHONDRIAL MYOPATHIES BY PHOSPHORUS MAGNETIC-RESONANCE SPECTROSCOPY [J].
ARNOLD, DL ;
TAYLOR, DJ ;
RADDA, GK .
ANNALS OF NEUROLOGY, 1985, 18 (02) :189-196
[3]   DEFECTIVE BRAIN ENERGY-METABOLISM SHOWN BY INVIVO P-31 MR SPECTROSCOPY IN 28 PATIENTS WITH MITOCHONDRIAL CYTOPATHIES [J].
BARBIROLI, B ;
MONTAGNA, P ;
MARTINELLI, P ;
LODI, R ;
IOTTI, S ;
CORTELLI, P ;
FUNICELLO, R ;
ZANIOL, P .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1993, 13 (03) :469-474
[4]  
BARKOVICH AJ, 1993, AM J NEURORADIOL, V14, P1119
[5]   Inhibition of N-acetylaspartate production: Implications for H-1 MRS studies in vivo [J].
Bates, TE ;
Strangward, M ;
Keelan, J ;
Davey, GP ;
Munro, PMG ;
Clark, JB .
NEUROREPORT, 1996, 7 (08) :1397-1400
[6]  
CASTILLO M, 1995, AM J NEURORADIOL, V16, P233
[7]   CONTROL OF OXIDATIVE-METABOLISM AND OXYGEN DELIVERY IN HUMAN SKELETAL-MUSCLE - A STEADY-STATE ANALYSIS OF THE WORK ENERGY-COST TRANSFER-FUNCTION [J].
CHANCE, B ;
LEIGH, JS ;
CLARK, BJ ;
MARIS, J ;
KENT, J ;
NIOKA, S ;
SMITH, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (24) :8384-8388
[8]   Epidemiology and treatment of mitochondrial disorders [J].
Chinnery, PF ;
Turnbull, DM .
AMERICAN JOURNAL OF MEDICAL GENETICS, 2001, 106 (01) :94-101
[9]   MELAS: Clinical and pathologic correlations with MRI, xenon/CT, and MR spectroscopy [J].
Clark, JM ;
Marks, MP ;
Adalsteinsson, E ;
Spielman, DM ;
Shuster, D ;
Horoupian, D ;
Albers, GW .
NEUROLOGY, 1996, 46 (01) :223-227
[10]  
Danielsen E.R., 1999, MAGNETIC RESONANCE S